Nabriva Therapeutics plc Annual Return On Equity in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nabriva Therapeutics plc quarterly/annual Return On Equity history and growth rate from 2017 to 2022.
  • Nabriva Therapeutics plc Return On Equity for the quarter ending June 30, 2023 was -2.67K %, a 2708% decline year-over-year.
  • Nabriva Therapeutics plc annual Return On Equity for 2022 was -212 %, a 158% decline from 2021.
  • Nabriva Therapeutics plc annual Return On Equity for 2021 was -82.1 %, a 60.5% increase from 2020.
  • Nabriva Therapeutics plc annual Return On Equity for 2020 was -208 %, a 15.5% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -212 -129 -158% Jan 1, 2022 Dec 31, 2022
2021 -82.1 +126 +60.5% Jan 1, 2021 Dec 31, 2021
2020 -208 -27.9 -15.5% Jan 1, 2020 Dec 31, 2020
2019 -180 -40 -28.6% Jan 1, 2019 Dec 31, 2019
2018 -140 -39.9 -39.9% Jan 1, 2018 Dec 31, 2018
2017 -100 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.